| Author: | Brian Andrews | ISBN: | 9781611457674 |
| Publisher: | Skyhorse Publishing | Publication: | April 12, 2012 |
| Imprint: | Arcade Publishing | Language: | English |
| Author: | Brian Andrews |
| ISBN: | 9781611457674 |
| Publisher: | Skyhorse Publishing |
| Publication: | April 12, 2012 |
| Imprint: | Arcade Publishing |
| Language: | English |
“A smart, hard-driving thriller” about genetic exploitation and biomedical ethics from the Wall Street Journal–bestselling coauthor of Tier One (Grant Blackwood, New York Times–bestselling author).
For one hundred and fifty-five days, Will Foster has been locked in medical quarantine without his consent. The doctors claim he is infected with a deadly virus—but that is a lie. Encoded in his DNA is a mutation that provides immunity from disease for all who possess it, source code that Vyrogen Pharmaceuticals aims to commercialize as a multi-billion-dollar gene therapy.
Against all odds, Foster escapes his laboratory prison and steals a virulent strain of bubonic plague as insurance. To help unravel the mystery inside him, Foster contacts the only person he can trust: a former lover and microbiologist living in Vienna. But soon the two become fugitives, hunted across Europe.
Under the guise of averting a plague pandemic, Vyrogen hires an elite, underground think tank to track down Foster. But the brilliant team discovers something unexpected—the ugly side of multinational pharmaceutical competition—and must choose between serving their client and saving Foster.
Brian Andrews’s debut thriller deftly explores the issues of genetic exploitation and piracy with nonstop suspense, unforgettable characters, and riveting biomedical detail—and sets the stage for further Think Tank adventures.
“A smart, hard-driving thriller” about genetic exploitation and biomedical ethics from the Wall Street Journal–bestselling coauthor of Tier One (Grant Blackwood, New York Times–bestselling author).
For one hundred and fifty-five days, Will Foster has been locked in medical quarantine without his consent. The doctors claim he is infected with a deadly virus—but that is a lie. Encoded in his DNA is a mutation that provides immunity from disease for all who possess it, source code that Vyrogen Pharmaceuticals aims to commercialize as a multi-billion-dollar gene therapy.
Against all odds, Foster escapes his laboratory prison and steals a virulent strain of bubonic plague as insurance. To help unravel the mystery inside him, Foster contacts the only person he can trust: a former lover and microbiologist living in Vienna. But soon the two become fugitives, hunted across Europe.
Under the guise of averting a plague pandemic, Vyrogen hires an elite, underground think tank to track down Foster. But the brilliant team discovers something unexpected—the ugly side of multinational pharmaceutical competition—and must choose between serving their client and saving Foster.
Brian Andrews’s debut thriller deftly explores the issues of genetic exploitation and piracy with nonstop suspense, unforgettable characters, and riveting biomedical detail—and sets the stage for further Think Tank adventures.
